Cloud Banner

Pharmaceutical

Image

Asia-Pacific Left Ventricular Assist Device (LVAD) Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Feb 2022
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 311
  • No of Figures: 60

Asia-Pacific Left Ventricular Assist Device (LVAD) Market, By Product Type (Heart Pump, Controller, Batteries, Wires), Therapy (Bridge-To-Transplant (BTT) Therapy, Destination Therapy, Bridge-To-Candidacy (BTC) Therapy, Bridge-To-Recovery (BTR) Therapy), Age Group (Adult, Pediatric), Indication (Congestive Heart Failure, Congenital Heart Disease, Myocarditis, Cardiac Arrest, Familial Arrhythmias and Arrhythmic, Cardiomyopathies, Advanced Heart Failure, Others), Generation (Second Generation Devices, Third Generation Devices, First Generation Devices), Durability (Long-Term, Intermediate-Term, Short-Term), Design (Axial, Centrifugal), Pulse Type (Nonpulsatile, Pulsatile), End User (Hospitals, Cardiac Cath Laboratories, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2029.

Asia-Pacific Left Ventricular Assist Device (LVAD) Market

Market Analysis and Insights : Asia-Pacific Left Ventricular Assist Device (LVAD) Market

The left ventricular assist device (LVAD) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.8% in the forecast period of 2022 to 2029 and is expected to reach USD 298.94 million by 2029. Rising healthcare expenditure and rising prevalence of cardiac disease are acting as driver for the left ventricular assist device (LVAD) market growth.

Left ventricular assist device (LVAD) is a pump that we use for patients who have reached end-stage heart failure. Left ventricular assist device is surgically implanted and it’s a battery operated, mechanical pump that helps the left ventricle pump blood to the rest of the blood. LVADs can be used as bridge-to-transplant, destination therapy, bridge-to-candidacy therapy and bridge-to-recovery therapy.

Changing lifestyle triggers the development of cardiovascular diseases which has enhanced the requirement of left ventricular assist device (LVAD) products which improves patient outcomes and allows them to lead a better life hence acts as driver for the left ventricular assist device (LVAD) market. The complications and risks associated with LVAD and presence of alternative approaches including heart transplantation is expected to hinder the growth of left ventricular assist device (LVAD) market growth. Increase in healthcare expenditure and increase in minimally invasive procedure, thus acts as an opportunity for the left ventricular assist device (LVAD) market. Increase in product recall pose a serious safety risk to the public restrict the product manufacturers to earn potential benefit in the market and impacts the overall market size, hence acts as challenge for the left ventricular assist device (LVAD) market growth.

The left ventricular assist device (LVAD) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the Left Ventricular Assist Device (LVAD) market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia-Pacific Left Ventricular Assist Device (LVAD) Market

Left Ventricular Assist Device (LVAD) Market Scope and Market Size

The left ventricular assist device (LVAD) market is segmented on the based on the product type, therapy, age group, indication, generation, durability, design, pulse type, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product type, the left ventricular assist device (LVAD) market is segmented into heart pump, controller, batteries and wires. In 2022, heart pump segment is expected to dominate the left ventricular assist device (LVAD) market as heart pumps ensures the proper and vital functioning of left ventricular assist devices and enhances the patient satisfaction suffering from heart failure. Moreover, increasing number of heart failure is also accelerating the market growth.
  • On the basis of therapy, the left ventricular assist device (LVAD) market is segmented into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-candidacy (BTC) therapy, bridge-to-recovery (BTR) therapy. In 2022, bridge-to-transplant (BTT) therapy is expected to dominate the market as it is applicable to patients wait for further transplantation and also improves the quality of patients life as it pumps oxygen enriched blood.
  • On the basis of age group, the left ventricular assist device (LVAD) market is segmented into adult and pediatric. In 2022, adult is expected to dominate the market due to increasing geriatric population as heart failure mostly affects adult’s population lying in between the age of 55 years to 75 years.
  • On the basis of indication, the left ventricular assist device (LVAD) market is segmented into congestive heart failure, congenital heart disease, myocarditis, cardiac arrest, familial arrhythmias and arrhythmic, cardiomyopathies, advanced heart failure and others. In 2022, congestive heart failure segment is expected to dominate the market due to increasing obesity which leads to high rate of heart failures.
  • On the basis of generation, the left ventricular assist device (LVAD) market is segmented into second generation devices, third generation devices and first generation devices. In 2022, second generation devices segment is expected to dominate the market as most of the left ventricular assist devices available in the market are of second generation and these smaller devices offers easy implantation with low rates of driveline infections as compared to first generation devices.
  • On the basis of durability, the left ventricular assist device (LVAD) market is segmented into long-term, intermediate-term and short-term. In 2022, long-term segment is expected to dominate the market as these devices these acts as an alternative therapy to prevent patients suffering from heart failure.
  • On the basis of design, the left ventricular assist device (LVAD) market is segmented into axial and centrifugal. In 2022, axial segment is expected to dominate the market as these have been first approved in the market and still used by several manufacturers while designing LVAD. Moreover, axial segment improves quality of patient’s life especially in patients who survive the perioperative period.
  • On the basis of pulse type, the left ventricular assist device (LVAD) market is segmented into nonpulsatile and pulsatile. In 2022, nonpulsatile segment is expected to dominate the market as these are continuous-flow LVAD pumps which in turn improves the cardiac functional benefits in patients suffering from end-stage heart failure.
  • On the basis of end user, the left ventricular assist device (LVAD) market is segmented into hospitals, specialty clinics, cardiac cath laboratories and others. In 2022, the hospitals segment is expected to dominate the market due to availability of technologically advanced left ventricular assist devices and presence of trained healthcare professionals.
  • On the basis of distribution channel, the left ventricular assist device (LVAD) market is segmented into direct tender, retail sales and others. In 2022, the direct tender segment is expected to dominate the market as direct tenders offers high quality left ventricular assist devices in a cost-effective manner.

Left Ventricular Assist Device (LVAD) Market Country Level Analysis

The left ventricular assist device (LVAD) market is analyzed and market size information is provided by the country, product type, therapy, age group, indication, generation, durability, design, pulse type, end user, and distribution channel as referenced above.

The countries covered in the left ventricular assist device (LVAD) market report are the China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific.

Heart pump segment in Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2022 to 2029 due to increasing population prone to chronic cardiovascular diseases. The heart pump segment in Japan is dominating the Asia-Pacific left ventricular assist device (LVAD) market due to increasing technological advancement and rising cases of end-stage failure heart diseases.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Favorable Reimbursement Policies Enhanced the Demand for LVAD treatment for Cardiac Diseases and Increasing Product Launches is Boosting the Market Growth of Left Ventricular Assist Device (LVAD) Market

The left ventricular assist device (LVAD) market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2011 to 2020.

Competitive Landscape and Left Ventricular Assist Device (LVAD) Market Share Analysis

Left ventricular assist device (LVAD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to left ventricular assist device (LVAD) market.

The major companies which are dealing in the left ventricular assist device (LVAD) are Abbott, Evaheart, Inc, Saft (A Subsidiary of TotalEnergies), ABIOMED, Berlin Heart, CorWave SA, Jarvik Heart, Inc.among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Launch of new programme for development of advanced left ventricular devices across Asia-Pacific countries is accelerating the left ventricular assist device (LVAD) market.

For instance,

  • In February 2021, IIT-Kanpur launched a project to develop advanced artificial left-ventricular assist device in collaboration with nation’s leading hospitals. This programme has been launched for not only to enrich the health ecosystem of the country but also enhance the innovation and to improve the biomedical research.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company footprints in the left ventricular assist device (LVAD) market which also provides the benefit for organization’s profit growth.


SKU-

TABLE 1 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 ASIA PACIFIC HEART PUMP IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 ASIA PACIFIC CONTROLLER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 ASIA PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 5 ASIA PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 ASIA PACIFIC WIRES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 7 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 8 ASIA PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 ASIA PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 10 ASIA PACIFIC DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 ASIA PACIFIC DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 12 ASIA PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 13 ASIA PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 14 ASIA PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 15 ASIA PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 16 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 17 ASIA PACIFIC ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 ASIA PACIFIC ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 19 ASIA PACIFIC PEDIATRIC IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 21 ASIA PACIFIC SECOND GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 ASIA PACIFIC THIRD GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 ASIA PACIFIC FIRST GENERATION DEVICES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 25 ASIA PACIFIC AXIAL IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 ASIA PACIFIC CENTRIFUGAL IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 28 ASIA PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 ASIA PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 30 ASIA PACIFIC CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 ASIA PACIFIC CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 32 ASIA PACIFIC MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 ASIA PACIFIC MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 34 ASIA PACIFIC CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 ASIA PACIFIC CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 36 ASIA PACIFIC FAMILIAL ARRHYTHYMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 ASIA PACIFIC FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 38 ASIA PACIFIC ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 ASIA PACIFIC ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 40 ASIA PACIFIC OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 42 ASIA PACIFIC LONG TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 ASIA PACIFIC INTERMEDIATE-TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 ASIA PACIFIC SHORT-TERM IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION))

TABLE 45 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 46 ASIA PACIFIC NONPULSATILE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 ASIA PACIFIC PULSATILE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 48 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 49 ASIA PACIFIC HOSPITALS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 ASIA PACIFIC CARDIAC CATH LABORATORIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 ASIA PACIFIC SPECIALTY CLINICS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 ASIA PACIFIC OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 53 ASIA PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 54 ASIA PACIFIC DIRECT TENDER IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 ASIA PACIFIC RETAIL SALES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 56 ASIA PACIFIC OTHERS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 57 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

TABLE 58 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 59 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 60 ASIA-PACIFIC BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 61 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 62 ASIA-PACIFIC BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 63 ASIA-PACIFIC DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 64 ASIA-PACIFIC BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 65 ASIA-PACIFIC BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 66 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 67 ASIA-PACIFIC ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 68 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 69 ASIA-PACIFIC CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 70 ASIA-PACIFIC CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 71 ASIA-PACIFIC MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 72 ASIA-PACIFIC CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 73 ASIA-PACIFIC FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 74 ASIA-PACIFIC ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 75 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 76 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 77 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 78 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 79 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 80 ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 81 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 82 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 83 JAPAN BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 84 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 85 JAPAN BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 86 JAPAN DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 87 JAPAN BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 88 JAPAN BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 89 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 90 JAPAN ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 91 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 92 JAPAN CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 93 JAPAN CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 94 JAPAN MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 95 JAPAN CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 96 JAPAN FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 97 JAPAN ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 98 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 99 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 100 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 101 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 102 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 103 JAPAN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 104 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 105 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 106 CHINA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 107 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 108 CHINA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 109 CHINA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 110 CHINA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 111 CHINA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 112 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 113 CHINA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 114 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 115 CHINA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 116 CHINA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 117 CHINA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 118 CHINA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 119 CHINA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 120 CHINA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 121 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 122 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 123 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 124 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 125 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 126 CHINA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 127 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 128 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 129 SOUTH KOREA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 130 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 131 SOUTH KOREA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 132 SOUTH KOREA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 133 SOUTH KOREA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 134 SOUTH KOREA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 135 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 136 SOUTH KOREA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 137 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 138 SOUTH KOREA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 139 SOUTH KOREA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 140 SOUTH KOREA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 141 SOUTH KOREA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 142 SOUTH KOREA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 143 SOUTH KOREA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 144 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 145 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 146 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 147 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 148 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 149 SOUTH KOREA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 150 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 151 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 152 INDIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 153 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 154 INDIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 155 INDIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 156 INDIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 157 INDIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 158 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 159 INDIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 160 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 161 INDIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 162 INDIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 163 INDIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 164 INDIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 165 INDIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 166 INDIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 167 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 168 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 169 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 170 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 171 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 172 INDIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 173 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 174 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 175 AUSTRALIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 176 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 177 AUSTRALIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 178 AUSTRALIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 179 AUSTRALIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 180 AUSTRALIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 181 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 182 AUSTRALIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 183 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 184 AUSTRALIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 185 AUSTRALIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 186 AUSTRALIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 187 AUSTRALIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 188 AUSTRALIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 189 AUSTRALIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 190 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 191 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 192 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 193 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 194 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 195 AUSTRALIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 196 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 197 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 198 SINGAPORE BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 199 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 200 SINGAPORE BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 201 SINGAPORE DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 202 SINGAPORE BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 203 SINGAPORE BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 204 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 205 SINGAPORE ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 206 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 207 SINGAPORE CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 208 SINGAPORE CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 209 SINGAPORE MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 210 SINGAPORE CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 211 SINGAPORE FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 212 SINGAPORE ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 213 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 214 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 215 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 216 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 217 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 218 SINGAPORE LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 219 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 220 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 221 THAILAND BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 222 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 223 THAILAND BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 224 THAILAND DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 225 THAILAND BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 226 THAILAND BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 227 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 228 THAILAND ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 229 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 230 THAILAND CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 231 THAILAND CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 232 THAILAND MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 233 THAILAND CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 234 THAILAND FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 235 THAILAND ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 236 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 237 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 238 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 239 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 240 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 241 THAILAND LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 242 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 243 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 244 MALAYSIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 245 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 246 MALAYSIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 247 MALAYSIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 248 MALAYSIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 249 MALAYSIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 250 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 251 MALAYSIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 252 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 253 MALAYSIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 254 MALAYSIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 255 MALAYSIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 256 MALAYSIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 257 MALAYSIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 258 MALAYSIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 259 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 260 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 261 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 262 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 263 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 264 MALAYSIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 265 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 266 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 267 PHILIPPINES BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 268 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 269 PHILIPPINES BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 270 PHILIPPINES DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 271 PHILIPPINES BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 272 PHILIPPINES BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 273 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 274 PHILIPPINES ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 275 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 276 PHILIPPINES CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 277 PHILIPPINES CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 278 PHILIPPINES MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 279 PHILIPPINES CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 280 PHILIPPINES FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 281 PHILIPPINES ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 282 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 283 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 284 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 285 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 286 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 287 PHILIPPINES LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 288 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 289 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (UNITS)

TABLE 290 INDONESIA BATTERIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 291 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 292 INDONESIA BRIDGE-TO-TRANSPLANT (BTT) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 293 INDONESIA DESTINATION THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 294 INDONESIA BRIDGE-TO-CANDIDACY (BTC) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 295 INDONESIA BRIDGE-TO-RECOVERY (BTR) THERAPY IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY THERAPY, 2020-2029 (USD MILLION)

TABLE 296 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 297 INDONESIA ADULT IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 298 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 299 INDONESIA CONGESTIVE HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 300 INDONESIA CONGENITAL HEART DISEASE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 301 INDONESIA MYOCARDITIS IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 302 INDONESIA CARDIAC ARREST IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 303 INDONESIA FAMILIAL ARRHYTHMIAS AND ARRHYTHMIC CARDIOMYOPATHIES IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 304 INDONESIA ADVANCED HEART FAILURE IN LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY INDICATION, 2020-2029 (USD MILLION)

TABLE 305 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY GENERATION, 2020-2029 (USD MILLION)

TABLE 306 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DURABILITY, 2020-2029 (USD MILLION)

TABLE 307 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DESIGN, 2020-2029 (USD MILLION)

TABLE 308 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PULSE TYPE, 2020-2029 (USD MILLION)

TABLE 309 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 310 INDONESIA LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 311 REST OF ASIA-PACIFIC LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

Asia-Pacific Left Ventricular Assist Device (LVAD) Market is growing with a CAGR of 10.8% during the forecast period of 2022 to 2029.
Asia-Pacific Left Ventricular Assist Device (LVAD) Market is expected to reach USD 298.94 million during the forecast period of 2022 to 2029
Asia-Pacific Left Ventricular Assist Device (LVAD) Market segmented By Product Type such as Heart Pump, Controller, Batteries, Wires.
The major companies which are dealing in the left ventricular assist device (LVAD) are Abbott, Evaheart, Inc, Saft (A Subsidiary of TotalEnergies), ABIOMED, Berlin Heart, CorWave SA, Jarvik Heart, Inc.among other domestic players.
The left ventricular assist device (LVAD) market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials